Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers

Human Pathology

Volumn 27, Issue 7, 1996, Pages 720-727

  König, Josee J ^a   Teubel, Wilma ^a   Romijn, Johannes C ^a   Schröder, Fritz H ^a   Hagemeijer, Anne ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

benign prostatic hyperplasia; clinical correlation; DNA flow cytometry; fluorescence in situ hybridization; prostatic carcinoma

Indexed keywords

ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 18; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME LOSS; DISEASE ASSOCIATION; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; Y CHROMOSOME;

EID: 0029943289     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90404-9     Document Type: Article

References (38)

1. Sandberg AA: Chromosomal abnormalities and related events in prostate cancer. HUM PATHOL 23:368-380, 1992
2. König JJ, Teubel W, van Dongen JJW, et al: Tissue culture loss of aneuploid cells from carcinomas of the prostate. Genes Chrom Cancer 8:22-27, 1993
3. König JJ, van Dongen JJW, Schröder FH: Preferential loss of abnormal prostate carcinoma cells by collagenase treatment. Cytometry 14:805-810, 1993
4. Breitkreuz T, Romanakis K, Lutz S, et al: Genotypic characterization of prostatic carcinomas: A combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res 53:4035-4040, 1993
5. Micale MA, Sanford JS, Powell IJ, et al: Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: Paraffin FISH vs metaphase analysis. Cancer Genet Cytogenet 69:7-12, 1993
6. Brothman AR, Watson MJ, Zhu XL, et al: Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 75:40-44, 1994
7. Baretton GB, Valina C, Vogt T, et al: Interphase cytogenetics of prostatic carcinomas by use of nonisotopic in situ hybridization. Cancer Res 54:4472-4480, 1994
8. Zincke H, Bergstralh EJ, Larson-Keller JJ, et al: Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment: Evidence for favorable survival in patients with DNA diploid tumors. Cancer 70:312-323, 1992
9. Lundgren R, Heim S, Mandahl N, et al: Chromosome abnormalities are associated with unfavorable outcome in prostate cancer patients. J Urol 147:784-788, 1992
10. Macoska JA, Micale MA, Sakr WA, et al: Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromos Cancer 8:88-97, 1993
11. Bandyk MG, Zhao L, Troncoso P, et al: Trisomy 7: A potential cytogenetic marker of human prostate cancer progression. Genes Chromos Cancer 9:19-27, 1994
12. König JJ, Teubel W, van Dongen JJW, et al: Loss and gain of chromosomes 1, 18 and Yin prostate cancer. Prostate 25:281-291, 1994
13. Schröder FH, Hermanek P, Denis L, et al: The TNM classification of prostate cancer. Prostate 4:129-138, 1992 (suppl)
14. Cooke HJ, Hindley J: Cloning of human satellite III DNA: Different components are on different chromosomes. Nucl Acids Res 6:3177-197, 1979
15. Waye S, England SB, Willard HF: Genomic organization of a satellite DNA on human chromosome 7: Evidence for two distinct alphoid domains on a single chromosome. Mol Cell Biol 7:349-356, 1987
16. Donlon T, Wyman AR, Mulholland J, et al: a Satellite-like sequences at the centromeres of chromosome #8. Am J Hum Genet 39:A196, 1986
17. Devilee P, Kievits T, Waye JS, et al: Chromosome-specific a satellite DNA: Isolation and mapping of a polymorphic alphoid repeat from human chromosome 10. Genomics 3:1-7, 1988
18. Devilee P, Cremer T, Slagboom P, et al: Two subsets of human alphoid repetitive DNA show distinct preferential localization in the pericentric regions of chromosomes 13, 18 and 21. Cytogenet Cell Genet 41:193-201, 1986
19. Hopman AHN, Ramaekers FCS, Raap AK, et al: In situ hybridization as a tool to study numerical chromosome aberrations in solid tumors. Histochemistry 89:307-316, 1988
20. Aly M, Dal Cin P, van de Voorde W, et al: Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromos Cancer 9:227-233, 1994
21. Arps S, Rodewald A, Schmalenberger B, et al: Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99, 1993
22. Bergerheim USR, Kunimi K, Collins VP, et al: Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chrom Cancer 3:215-220, 1991
23. Carter BS, Ewing CM, Ward WS, et al: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755, 1990
24. Kunimi K, Bergerheim USR, Larsson IL, et al: Allelotyping of human prostatic adenocarcinoma. Genomics 11:530-536, 1991
25. König JJ, Kamst E, Hagemeijer A, et al: Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP. Urol Res 17:79-86, 1989
26. Macoska JA, Trybus TM, Sakr WA, et al: Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54:3824-3830, 1994
27. Cher ML, MacGrogan D, Bookstein R, et al: Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromos Cancer 11:153-162, 1994
28. Matsuyama H, Pan Y, Skoog L, et al: Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 9:3071-3076, 1994
29. Bova GS, Carter BS, Bussemakers MJG, et al: Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873, 1993
30. MacGrogan D, Levy A, Bostwick D, et al: Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalance. Genes Chromos Cancer 10:151-159, 1994
31. Trapman J, Sleddens HFBM, van der Weiden MM, et al: Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54:6061-6064, 1994
32. Micale MA, Mohamed A, Sakr W, et al: Cytogenetics of primary prostatic adenocarcinoma: Clonality and chromosome instability. Cancer Genet Cytogenet 61:165-173, 1992
33. Jones E, Zhu XL, Rohr LR, et al: Aneusomy of chromosome 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chromos Cancer 11:163-170, 1994
34. Alcaraz A, Takahashi S, Brown JA, et al: Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002, 1994
35. Visakorpi T, Kallioniemi A, Syvanen A, et al: Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347, 1995
36. Latil A, Baron J, Cussenot O, et al: Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q. Genes Chromos Cancer 11:119-125, 1994
37. Shackney SE, Smith CA, Miller BW, et al: Model for the genetic evolution of human solid tumors. Cancer Res 49:3344-3354, 1989
38. Casalone R, Portentoso P, Granata P, et al: Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma. Cancer Genet Cytogenet 68:126-130, 1993